Advertisement
UK markets closed

  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     

  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     

  • AIM

    789.87
    +6.17 (+0.79%)
     

  • GBP/EUR

    1.1630
    +0.0019 (+0.16%)
     

  • GBP/USD

    1.2533
    +0.0009 (+0.08%)
     

  • Bitcoin GBP

    48,228.96
    -1,116.62 (-2.26%)
     

  • CMC Crypto 200

    1,261.22
    -96.79 (-7.12%)
     

  • S&P 500

    5,214.88
    +0.80 (+0.02%)
     

  • DOW

    39,468.85
    +81.09 (+0.21%)
     

  • CRUDE OIL

    78.32
    -0.94 (-1.19%)
     

  • GOLD FUTURES

    2,374.90
    +34.60 (+1.48%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     

  • DAX

    18,772.85
    +86.25 (+0.46%)
     

  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     
MONEY:

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

Why Inovio Pharmaceuticals Is Gaining Today

Alex Carchidi, The Motley Fool
·2-min read

Inovio Pharmaceuticals' (NASDAQ: INO) stock rose by more than 18.5% as of 2:30 p.m. ET on Wednesday after the company's Q2 earnings results broke the news of its plans to restructure its operations to conserve cash. The biotech will lay off 18% of its full-time employees while additionally reducing its contractor head count by a massive 86%. Inovio also announced the appointment of a new chief medical officer, Dr. Michael Sumner, which might be another contributing factor to the gain of its stock today.

Continue reading